Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-02-15 | Dr. Robert D. AllenChief Scientific Officer | 61,42k | 0,00 | Derivative Exercise and Retained Stock | - | 114,49k | 115,74% |
| 2026-02-15 | Dr. Robert D. AllenChief Scientific Officer | -37,58k | 58,60k | Derivative Exercise and Sale | 1,54 - 1,58 | 114,49k | - |
| 2026-02-15 | Ms. Julie GreenChief HR Officer | 58,37k | 0,00 | Derivative Exercise and Retained Stock | - | 107,72k | 118,30% |
| 2026-02-15 | Ms. Julie GreenChief HR Officer | -40,63k | 63,35k | Derivative Exercise and Sale | 1,54 - 1,58 | 107,72k | - |
| 2026-02-15 | Mr. William E. DukeCFO, Principal Accounting Officer & Principal Executive Officer | 58,37k | 0,00 | Derivative Exercise and Retained Stock | - | 107,72k | 118,30% |
| 2026-02-15 | Mr. William E. DukeCFO, Principal Accounting Officer & Principal Executive Officer | -40,63k | 63,35k | Derivative Exercise and Sale | 1,54 - 1,58 | 107,72k | - |
| 2026-02-15 | Mr. Timothy LeeChief Commercial Officer | 58,37k | 0,00 | Derivative Exercise and Retained Stock | - | 117,72k | 98,36% |
| 2026-02-15 | Mr. Timothy LeeChief Commercial Officer | -40,63k | 63,35k | Derivative Exercise and Sale | 1,54 - 1,58 | 117,72k | - |
| 2026-02-15 | Ms. Jill AndersenChief Legal Officer & Corporate Secretary | 97,29k | 0,00 | Derivative Exercise and Retained Stock | - | 182,24k | 114,53% |
| 2026-02-15 | Ms. Jill AndersenChief Legal Officer & Corporate Secretary | -67,71k | 105,58k | Derivative Exercise and Sale | 1,54 - 1,58 | 182,24k | - |
| 2025-12-23 | Adimab, LLCSocietà | -192,32k | 577,50k | Vendita | 3,00 | 20,26M | -0,94% |
| 2025-11-19 | Mr. Kevin F. McLaughlinIndependent Director | 50,00k | 125,00k | Acquisto | 2,50 | 50,00k | - |
| 2025-11-17 | Adimab, LLCSocietà | -1,23M | 3,70M | Vendita | 3,00 | 20,45M | -5,69% |
| 2025-08-15 | Mr. Timothy LeeChief Commercial Officer | 49,34k | 0,00 | Derivative Exercise and Retained Stock | - | 59,34k | 493,44% |
| 2025-08-15 | Mr. Timothy LeeChief Commercial Officer | -49,66k | 29,81k | Derivative Exercise and Sale | 0,57 - 0,65 | 59,34k | - |
| 2025-08-15 | Mr. William E. DukeCFO, Principal Accounting Officer & Principal Executive Officer | -49,66k | 29,81k | Derivative Exercise and Sale | 0,57 - 0,65 | 49,34k | - |
| 2025-08-15 | Mr. William E. DukeCFO, Principal Accounting Officer & Principal Executive Officer | 49,34k | 0,00 | Derivative Exercise and Retained Stock | - | 49,34k | - |
| 2025-08-15 | Ms. Julie GreenChief HR Officer | 49,34k | 0,00 | Derivative Exercise and Retained Stock | - | 49,34k | - |
| 2025-08-15 | Ms. Julie GreenChief HR Officer | -49,66k | 29,81k | Derivative Exercise and Sale | 0,57 - 0,65 | 49,34k | - |
| 2025-08-15 | Ms. Jill AndersenChief Legal Officer & Corporate Secretary | 82,25k | 0,00 | Derivative Exercise and Retained Stock | - | 84,95k | 3.046,15% |
| 2025-08-15 | Ms. Jill AndersenChief Legal Officer & Corporate Secretary | -82,75k | 49,68k | Derivative Exercise and Sale | 0,57 - 0,65 | 84,95k | - |
| 2025-08-15 | Dr. Robert D. AllenChief Scientific Officer | 53,07k | 0,00 | Derivative Exercise and Retained Stock | - | 53,07k | - |
| 2025-08-15 | Dr. Robert D. AllenChief Scientific Officer | -45,93k | 27,57k | Derivative Exercise and Sale | 0,57 - 0,65 | 53,07k | - |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
